CompletedNCT04128683
Dopamine and Learning From Outcomes in Anorexia
About this title
Dopamine Receptor Contributions to Prediction Error and Reversal Learning in Anorexia Nervosa
Read the official source — NCT04128683Medication studyAges 18–29United StatesEating disorders
Understand this study
Who was this study for?
Listed age limits: 18 years to 29 years.
- Listed locations
- San DiegoSee all locations and recruitment
- Study phase
- Early phase 1An early first-in-human or very early safety study, usually focused on how a treatment behaves in the body.
Study information
Study start dateStarted: October 20, 2020
- Recruitment status
- Completed
- Enrollment listed in the registry
- 31
- Sponsor
- University of California, San Diego
- Sponsor type
- University
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Early Phase 1An early first-in-human or very early safety study, usually focused on how a treatment behaves in the body.
- Locations
- United States
- Age range
- From 18 Years to 29 Years
- Official registry ID
- NCT04128683
- Official title
Show the full official title
Toward Understanding Dopamine Receptor Contributions to Prediction Error and Reversal Learning in Anorexia Nervosa
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
San Diego
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is University of California, San Diego, a university.
Did this study involve medication?
Yes. The study involved medication, including amisulpride, bromocriptine and Placebo.
Who was this study for?
Listed age limits: 18 years to 29 years.
